Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hypertension

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    April 2018
  1. WENGER NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, et al
    Hypertension Across a Woman's Life Cycle.
    J Am Coll Cardiol. 2018;71:1797-1813.
    PubMed     Text format     Abstract available


  2. JURASCHEK SP, Miller ER 3rd, Appel LJ
    Reply: The Role of Salt Reduction in the Management of Hypertension.
    J Am Coll Cardiol. 2018;71:1598-1599.
    PubMed     Text format    


  3. BLUMENTHAL JA, Sherwood A, Smith PJ, Hinderliter A, et al
    The Role of Salt Reduction in the Management of Hypertension.
    J Am Coll Cardiol. 2018;71:1597-1598.
    PubMed     Text format    


  4. MESSERLI FH, Bangalore S, Bavishi C, Rimoldi SF, et al
    Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    J Am Coll Cardiol. 2018;71:1474-1482.
    PubMed     Text format     Abstract available


    March 2018
  5. WHITE WB
    Clinical Precision in the Management of Hypertension: Improving Upon the "One-Size-Fits-All" Approach.
    J Am Coll Cardiol. 2018 Mar 2. pii: S0735-1097(18)33228.
    PubMed     Text format    


  6. PHILLIPS RA, Xu J, Peterson LE, Arnold RM, et al
    Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    J Am Coll Cardiol. 2018 Mar 2. pii: S0735-1097(18)33226.
    PubMed     Text format     Abstract available


    February 2018
  7. JIMENEZ D, Quezada CA, Escribano P
    Surrogate Endpoints for Pulmonary Hypertension Management and Trial Design: Moving in the Right Direction.
    J Am Coll Cardiol. 2018;71:764-765.
    PubMed     Text format    


  8. MCLAUGHLIN VV, Hoeper MM, Channick RN, Chin KM, et al
    Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
    J Am Coll Cardiol. 2018;71:752-763.
    PubMed     Text format     Abstract available


    December 2017
  9. JURASCHEK SP, Miller ER 3rd, Weaver CM, Appel LJ, et al
    Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.
    J Am Coll Cardiol. 2017;70:2841-2848.
    PubMed     Text format     Abstract available


    November 2017
  10. SAIA F, Palazzini M, Taglieri N, Manes A, et al
    Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2460-2461.
    PubMed     Text format    


  11. MONTERO CABEZAS JM, Nuche Berenguer J, Velazquez Martin MT, Escribano Subias P, et al
    Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2459-2460.
    PubMed     Text format    


  12. REDDY YNV, Borlaug BA
    Reply: Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458-2459.
    PubMed     Text format    


  13. MESSERLI FH, Rimoldi SF, Wilhelm M
    Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458.
    PubMed     Text format    


    October 2017
  14. HONG KN, Fuster V, Rosenson RS, Rosendorff C, et al
    How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    J Am Coll Cardiol. 2017;70:2171-2185.
    PubMed     Text format     Abstract available


    August 2017
  15. SELVARAJ S, Djousse L, Aguilar FG, Martinez EE, et al
    Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study.
    J Am Coll Cardiol. 2017;70:715-724.
    PubMed     Text format     Abstract available


    July 2017
  16. BAVISHI C, Bangalore S, Messerli FH
    Reply: Hypertension Treatment in the Elderly: Individualized Target or Intensive Blood Pressure Lowering?
    J Am Coll Cardiol. 2017;70:510.
    PubMed     Text format    


  17. ABDELKARIM I, Althouse AD, Thoma FW, Lee JS, et al
    The Importance of Invasive Hemodynamics for Pulmonary Hypertension Screening in TAVR Patients.
    J Am Coll Cardiol. 2017;70:510-511.
    PubMed     Text format    


  18. HUANG Y, Li M, Huang W
    Hypertension Treatment in the Elderly: Individualized Target or Intensive Blood Pressure Lowering?
    J Am Coll Cardiol. 2017;70:509-510.
    PubMed     Text format    


  19. BAVISHI C, Bangalore S, Messerli FH
    Reply: Adequate Blood Pressure Control and Monitoring Acute Kidney Injury in Older Hypertensive Patients.
    J Am Coll Cardiol. 2017;70:120.
    PubMed     Text format    


  20. NARANJO M, Mezue K, Rangaswami J
    Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients: Should AKI Be Watched?
    J Am Coll Cardiol. 2017;70:119-120.
    PubMed     Text format    


    June 2017
  21. HUANG Y, Huang W, Hu Y
    Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    J Am Coll Cardiol. 2017;69:2880.
    PubMed     Text format    


  22. FRANKLIN SS, Thijs L, Staessen JA
    Reply: Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    J Am Coll Cardiol. 2017;69:2880-2881.
    PubMed     Text format    


  23. ALFONSO F, Rivero F
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2017;69:2818-2820.
    PubMed     Text format    


  24. GALIE N, Saia F, Palazzini M, Manes A, et al
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.
    J Am Coll Cardiol. 2017;69:2808-2817.
    PubMed     Text format     Abstract available


    May 2017
  25. HANSMANN G
    Pulmonary Hypertension in Infants, Children, and Young Adults.
    J Am Coll Cardiol. 2017;69:2551-2569.
    PubMed     Text format     Abstract available


  26. MUNTNER P, Whelton PK
    Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.
    J Am Coll Cardiol. 2017;69:2446-2456.
    PubMed     Text format     Abstract available


    April 2017
  27. MAIOLINO G, Calo LA, Rossi GP
    The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives.
    J Am Coll Cardiol. 2017;69:1821-1823.
    PubMed     Text format    


  28. GUAZZI M, Naeije R
    Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    J Am Coll Cardiol. 2017;69:1718-1734.
    PubMed     Text format     Abstract available


    March 2017
  29. MARCUS Y, Osher E, Stern N
    In the Treatment of Hypertension, Lowering of Diastolic Pressure to <70 mm Hg Is Often Unavoidable.
    J Am Coll Cardiol. 2017;69:1647-1648.
    PubMed     Text format    


  30. NADKARNI GN, Galarneau G, Ellis SB, Nadukuru R, et al
    Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
    J Am Coll Cardiol. 2017;69:1564-1574.
    PubMed     Text format     Abstract available


    February 2017
  31. MESSERLI FH, Rimoldi SF, Bangalore S, Bavishi C, et al
    Reply: Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    J Am Coll Cardiol. 2017;69:1100-1101.
    PubMed     Text format    


  32. PALATINI P
    Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    J Am Coll Cardiol. 2017;69:1099-1100.
    PubMed     Text format    


  33. SINGH RR, Sajeesh V, Booth LC, McArdle Z, et al
    Catheter-Based Renal Denervation Exacerbates Blood Pressure Fall During Hemorrhage.
    J Am Coll Cardiol. 2017;69:951-964.
    PubMed     Text format     Abstract available


  34. BAVISHI C, Bangalore S, Messerli FH
    Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients.
    J Am Coll Cardiol. 2017;69:486-493.
    PubMed     Text format     Abstract available


    January 2017
  35. VONK NOORDEGRAAF A, Westerhof BE, Westerhof N
    The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.
    J Am Coll Cardiol. 2017;69:236-243.
    PubMed     Text format     Abstract available


    December 2016
  36. LEOPOLD JA
    Biological Phenotyping of Combined Post-Capillary and Pre-Capillary Pulmonary Hypertension: Focus on Pulmonary Vascular Remodeling.
    J Am Coll Cardiol. 2016;68:2537-2539.
    PubMed     Text format    


  37. ASSAD TR, Hemnes AR, Larkin EK, Glazer AM, et al
    Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.
    J Am Coll Cardiol. 2016;68:2525-2536.
    PubMed     Text format     Abstract available


    November 2016
  38. MANCIA G, Grassi G
    The Heterogeneous Nature of White-Coat Hypertension.
    J Am Coll Cardiol. 2016;68:2044-2046.
    PubMed     Text format    


  39. FRANKLIN SS, Thijs L, Asayama K, Li Y, et al
    The Cardiovascular Risk of White-Coat Hypertension.
    J Am Coll Cardiol. 2016;68:2033-2043.
    PubMed     Text format     Abstract available


  40. SHINKURA Y, Nakayama K, Toba T, Takahashi H, et al
    TCT-91 Efficacy of aggressive balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension beyond normalized mean pulmonary arterial pressure.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  41. DANILOV N, Matchin Y, Yarovoy S, Sagaydak O, et al
    TCT-92 Short- and Long-Term Remodeling of Pulmonary Arteries After Balloon Angioplasty in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  42. BRENOT P, Garcia Alonso C, Gerardin B, Bourkaib R, et al
    TCT-89 Balloon pulmonary angioplasty for chronic thromboembolic hypertension: report of a two-year experience in a surgical center.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  43. YANAKA K, Nakayama K, Shinke T, Otake H, et al
    TCT-90 Efficacy and safety of sequential hybrid therapy with pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  44. RUDENKO B, Shanoian A, Boytsov S, Drapkina O, et al
    TCT-825 Simplicity Denervation System for Pulmonary Artery Denervation in Patients with Chronic Thrombembolic Pulmonary Hypertension (first-in-man study).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  45. KANMANTHAREDDY A, Saurav A, Koduri H, Pandya J, et al
    TCT-771 Clinical and Hemodynamic Efficacy of Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  46. FRANCISCO AR, Menezes MN, Lopes A, Correia H, et al
    TCT-765 Renal sympathetic denervation: impact on hypertensive disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  47. MAHFOUD F, Brilakis N, Bohm M, Narkiewicz K, et al
    TCT-761 Long-term (3-year) safety and effectiveness from the Global SYMPLICITY Registry of renal denervation in a real world patient population with uncontrolled hypertension.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  48. TESTA L
    TCT-704 Persistence of severe Pulmonary Hypertension after Transcatheter Aortic Valve Replacement: incidence and prognostic impact.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  49. CHEN SL
    TCT-500 Global right ventricular longitudinal peak systolic strain predicts clinical outcome after pulmonary artery denervation for patients with pulmonary arterial hypertension.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  50. COOK NR, Appel LJ, Whelton PK
    Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention.
    J Am Coll Cardiol. 2016;68:1609-1617.
    PubMed     Text format     Abstract available


    September 2016
  51. GOSMANOVA EO, Mikkelsen MK, Molnar MZ, Lu JL, et al
    Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    J Am Coll Cardiol. 2016;68:1375-86.
    PubMed     Text format     Abstract available


    July 2016
  52. BEN-YEHUDA O, Rubin LJ
    Pulmonary Hypertension Overlap Syndromes: A Real Entity?
    J Am Coll Cardiol. 2016;68:379-81.
    PubMed     Text format    


  53. OPITZ CF, Hoeper MM, Gibbs JS, Kaemmerer H, et al
    Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
    J Am Coll Cardiol. 2016;68:368-78.
    PubMed     Text format     Abstract available


    June 2016
  54. KO MJ, Jo AJ, Park CM, Kim HJ, et al
    Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    J Am Coll Cardiol. 2016;67:2821-31.
    PubMed     Text format     Abstract available


    May 2016
  55. RUBIN LJ
    Are Animal Models of Pulmonary Hypertension Relevant to the Clinical Disease?
    J Am Coll Cardiol. 2016;67:2047-9.
    PubMed     Text format    


  56. AGUERO J, Ishikawa K, Hadri L, Santos-Gallego CG, et al
    Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.
    J Am Coll Cardiol. 2016;67:2032-46.
    PubMed     Text format     Abstract available


    April 2016
  57. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    PubMed     Text format    


  58. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    PubMed     Text format    


  59. O'CONNOR S, Gornik HL, Froehlich JB, Gu X, et al
    Smoking and Adverse Outcomes in Fibromuscular Dysplasia: U.S. Registry Report.
    J Am Coll Cardiol. 2016;67:1750-1.
    PubMed     Text format    


  60. AGARWAL R
    Home Blood Pressure-Guided Antihypertensive Therapy Requires a Randomized Trial.
    J Am Coll Cardiol. 2016;67:1528-30.
    PubMed     Text format    


  61. HERTTUA K, Martikainen P, Batty GD, Kivimaki M, et al
    Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    J Am Coll Cardiol. 2016;67:1507-15.
    PubMed     Text format     Abstract available


  62. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.
    J Am Coll Cardiol. 2016;67:1519-27.
    PubMed     Text format     Abstract available


    March 2016
  63. LOBO MD
    Hypertension Landmark Trials 2015: A European Perspective of the Practicing Clinician.
    J Am Coll Cardiol. 2016;67:1372-4.
    PubMed     Text format    


  64. DOUWES JM, Humpl T, Bonnet D, Beghetti M, et al
    Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    J Am Coll Cardiol. 2016;67:1312-23.
    PubMed     Text format     Abstract available


  65. O'BYRNE ML, Rome JJ, Kawut SJ
    Reply: The Need for Comprehensive Cardiac Catheterization in Children With Pulmonary Hypertension: To "Cath" or Not in Pediatric Pulmonary Hypertension?
    J Am Coll Cardiol. 2016;67:1011-2.
    PubMed     Text format    


  66. BEGHETTI M, Berger RM, Ivy DD, Bonnet D, et al
    To "Cath" or Not in Pediatric Pulmonary Hypertension?
    J Am Coll Cardiol. 2016;67:1010-1.
    PubMed     Text format    


  67. HANSMANN G, Apitz C
    The Need for Comprehensive Cardiac Catheterization in Children With Pulmonary Hypertension.
    J Am Coll Cardiol. 2016;67:1009-10.
    PubMed     Text format    


    February 2016
  68. SANCHEZ-DE-LA-TORRE M, Barbe F
    Reply: Precision Medicine, Obstructive Sleep Apnea, and Refractory Hypertension.
    J Am Coll Cardiol. 2016;67:602.
    PubMed     Text format    


  69. CONTI R
    Precision Medicine, Obstructive Sleep Apnea, and Refractory Hypertension.
    J Am Coll Cardiol. 2016;67:601-2.
    PubMed     Text format    


  70. GRADMAN AH
    SPRINT: To Whom Do the Results Apply?
    J Am Coll Cardiol. 2016;67:473-5.
    PubMed     Text format    


  71. BRESS AP, Tanner RM, Hess R, Colantonio LD, et al
    Generalizability of SPRINT Results to the U.S. Adult Population.
    J Am Coll Cardiol. 2016;67:463-72.
    PubMed     Text format     Abstract available


  72. STERNLICHT H, Bakris GL
    Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit.
    J Am Coll Cardiol. 2016;67:390-1.
    PubMed     Text format    


  73. PAREEK AK, Messerli FH, Chandurkar NB, Dharmadhikari SK, et al
    Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.
    J Am Coll Cardiol. 2016;67:379-89.
    PubMed     Text format     Abstract available


    January 2016
  74. MOON JC, Treibel TA, Schelbert EB
    Myocardial Fibrosis in Hypertensive Heart Failure: Does Quality Rather Than Quantity Matter?
    J Am Coll Cardiol. 2016;67:261-3.
    PubMed     Text format    


  75. LOPEZ B, Ravassa S, Gonzalez A, Zubillaga E, et al
    Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
    J Am Coll Cardiol. 2016;67:251-60.
    PubMed     Text format     Abstract available


  76. CALVO E, Garcia-Alvarez A, Vazquez J
    The Quest for Metabolic Biomarkers of Pulmonary Hypertension.
    J Am Coll Cardiol. 2016;67:190-2.
    PubMed     Text format    


  77. LEWIS GD, Ngo D, Hemnes AR, Farrell L, et al
    Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.
    J Am Coll Cardiol. 2016;67:174-89.
    PubMed     Text format     Abstract available


    December 2015
  78. CARAVITA S, Faini A, Bilo G, Villafuerte FC, et al
    Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects.
    J Am Coll Cardiol. 2015;66:2806-7.
    PubMed     Text format    


  79. KISHI S, Teixido-Tura G, Venkatesh BA, Lima JA, et al
    Reply: Speckle-Tracking Echocardiography-Derived Longitudinal Dysfunction: A Novel Starting Point of the Hypertensive Patient's Journey Toward Heart Failure.
    J Am Coll Cardiol. 2015;66:2473.
    PubMed     Text format    


  80. GALDERISI M, Trimarco B
    Speckle-Tracking Echocardiography-Derived Longitudinal Dysfunction: A Novel Starting Point of the Hypertensive Patient's Journey Toward Heart Failure.
    J Am Coll Cardiol. 2015;66:2472.
    PubMed     Text format    


    November 2015
  81. VERDECCHIA P, Angeli F, Reboldi G
    Masked and White-Coat Hypertension: Moving to African Americans.
    J Am Coll Cardiol. 2015;66:2170-2.
    PubMed     Text format    


  82. TIENTCHEU D, Ayers C, Das SR, McGuire DK, et al
    Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
    J Am Coll Cardiol. 2015;66:2159-69.
    PubMed     Text format     Abstract available


    October 2015
  83. SCHULTZ MG, Otahal P, Picone DS, Sharman JE, et al
    Clinical Relevance of Exaggerated Exercise Blood Pressure.
    J Am Coll Cardiol. 2015;66:1843-5.
    PubMed     Text format    


  84. ARNETT DK
    Analysis of Large Electronic Health Record Databases Supports Blood Pressure-Incident Diabetes Association.
    J Am Coll Cardiol. 2015;66:1563-5.
    PubMed     Text format    


  85. EMDIN CA, Anderson SG, Woodward M, Rahimi K, et al
    Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies.
    J Am Coll Cardiol. 2015;66:1552-62.
    PubMed     Text format     Abstract available


    September 2015
  86. KOVACS RJ
    Using Practice-Based Evidence to Reduce Disparities in Care: A Virtuous Cycle Turns.
    J Am Coll Cardiol. 2015;66:1234-5.
    PubMed     Text format    


  87. SPERLING LS, Mechanick JI, Neeland IJ, Herrick CJ, et al
    The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome.
    J Am Coll Cardiol. 2015;66:1050-67.
    PubMed     Text format     Abstract available


    March 2015
  88. BI Y, Jiang Y, He J, Xu Y, et al
    Status of cardiovascular health in chinese adults.
    J Am Coll Cardiol. 2015;65:1013-25.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: